Robert Giugliano is a Cardiology physician. OpenAlex indexes 841 publications with 61,369 citations (h-index 105). By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St Pbb 1
Brigham And Womens Hospital Cardiovascualar Division
Boston, MA 02115
Telephone
617-732-5500Registry record last updated 4 May 2012.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20254 payments$16,771openpaymentsdata.cms.gov ↗
- Daiichi Sankyo Inc.Program year20253 payments
- Daiichi Sankyo Europe GmbHProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80%Statin24.1%Atorvastatin Calcium55%Rosuvastatin Calcium39%Pravastatin Sodium4%Simvastatin3%Part D<11 patientsBeta blocker15.6%Metoprolol Succinate78%Carvedilol15%Atenolol7%Part D<11 patients+ 12 more classes in this area
Blood & clotting
14.5%Factor Xa inhibitor11.1%Eliquis69%Xarelto23%Savaysa8%Part D<11 patientsP2Y12 inhibitor3.4%Clopidogrel100%Part D≥17 patientsMetabolism & gastrointestinal
4.8%SGLT2 inhibitor3.2%Jardiance57%Farxiga43%Part D<11 patientsPotassium supplement1.6%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex
Archive ouverte UNIGE (University of Geneva)
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”